PerPlexity Medical - Pharmaceuticals's Stock Coverage
| FFRFF EAI Robotics Ecosystem Inc | ― | ― | ― | ― | 27Ratings | -0.45% | ||
| INBPIntegrated BioPharma | Nov 01, 2026 | HOLD | Reiterated | $0.16 | 21Ratings | ― | ― | |
| MYXMayne Pharma Group | Nov 01, 2026 | HOLD | Reiterated | AU$2.50 | 18Ratings | ― | ― | |
| ADOCYAdocia | Nov 01, 2026 | SELL | Downgraded | $3.00 | 22Ratings | 0.00% | ||
| LFSTLifeist Wellness | Oct 31, 2026 | HOLD | Reiterated | C$0.03 | 31Ratings | +9.00% | ||
| INNOInnoCan Pharma | Oct 31, 2026 | HOLD | Reiterated | C$2.00 | 29Ratings | ― | ― | |
| SCYXSCYNEXIS | Oct 31, 2026 | HOLD | Reiterated | $4.00 | 40Ratings | +13.70% | ||
| SCNXScienture Holdings | Oct 31, 2026 | HOLD | Upgraded | $3.00 | 22Ratings | +21.10% | ||
| POMPomDoctor Ltd. Unsponsored ADR | Oct 31, 2026 | SELL | Reiterated | $1.50 | 48Ratings | +9.43% | ||
| PAVSParanovus Entertainment Technology | Oct 31, 2026 | SELL | Reiterated | $3.50 | 42Ratings | -35.80% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >PerPlexity Medical - Pharmaceuticals activity FAQ
What is the performance of PerPlexity Medical - Pharmaceuticals's recommendations?
The percentage of profitable recommendations made by PerPlexity Medical - Pharmaceuticals is 50.00%, and the average return per transaction is 4.70%.
What stocks does PerPlexity Medical - Pharmaceuticals cover?
PerPlexity Medical - Pharmaceuticals mostly covers Adocia, Mayne Pharma Group, Integrated BioPharma stocks.
What was PerPlexity Medical - Pharmaceuticals's most profitable rating?
PerPlexity Medical - Pharmaceuticals’s most profitable rating was a sell on PomDoctor Ltd. Unsponsored ADR stock on Feb 04, 2026. The return on the trade was 72.70%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here